Suivant

Bristol Myers Squibb CEO: With KarXT we'll be able to deliver good accuracy without the side ef

09/01/24
CNBC Télévision

Bristol Myers Squibb CEO Christopher Boerner joins 'Mad Money' host Jim Cramer to talk recent acquisitions made by the company, what's ahead for BMY and much more.

Montre plus

 0 commentaires sort   Trier par


Suivant